首页> 外文期刊>Journal of Cheminformatics >TCMSP: a database of systems pharmacology for drug discovery from herbal medicines
【24h】

TCMSP: a database of systems pharmacology for drug discovery from herbal medicines

机译:TCMSP:用于从草药中发现药物的系统药理数据库

获取原文
           

摘要

Background Modern medicine often clashes with traditional medicine such as Chinese herbal medicine because of the little understanding of the underlying mechanisms of action of the herbs. In an effort to promote integration of both sides and to accelerate the drug discovery from herbal medicines, an efficient systems pharmacology platform that represents ideal information convergence of pharmacochemistry, ADME properties, drug-likeness, drug targets, associated diseases and interaction networks, are urgently needed. Description The traditional Chinese medicine systems pharmacology database and analysis platform (TCMSP) was built based on the framework of systems pharmacology for herbal medicines. It consists of all the 499 Chinese herbs registered in the Chinese pharmacopoeia with 29,384 ingredients, 3,311 targets and 837 associated diseases. Twelve important ADME-related properties like human oral bioavailability, half-life, drug-likeness, Caco-2 permeability, blood-brain barrier and Lipinski’s rule of five are provided for drug screening and evaluation. TCMSP also provides drug targets and diseases of each active compound, which can automatically establish the compound-target and target-disease networks that let users view and analyze the drug action mechanisms. It is designed to fuel the development of herbal medicines and to promote integration of modern medicine and traditional medicine for drug discovery and development. Conclusions The particular strengths of TCMSP are the composition of the large number of herbal entries, and the ability to identify drug-target networks and drug-disease networks, which will help revealing the mechanisms of action of Chinese herbs, uncovering the nature of TCM theory and developing new herb-oriented drugs. TCMSP is freely available at http://sm.nwsuaf.edu.cn/lsp/tcmsp.php webcite.
机译:背景技术由于对草药的基本作用机理了解甚少,现代医学经常与诸如中草药的传统医学发生冲突。为了促进双方的整合并加速草药的药物发现,迫切需要一个有效的系统药理平台,该平台代表着理想的药理化学,ADME性质,药物相似性,药物靶标,相关疾病和相互作用网络信息融合需要。描述基于中草药系统药理学的框架,建立了中药系统药理学数据库和分析平台(TCMSP)。它由在中国药典中注册的所有499种中草药组成,包含29,384种成分,3,311种靶标和837种相关疾病。提供了十二种与ADME相关的重要属性,如人类口服生物利用度,半衰期,药物样,Caco-2渗透性,血脑屏障和Lipinski的5条规则,用于药物筛选和评估。 TCMSP还提供每种活性化合物的药物靶标和疾病,可以自动建立化合物靶标和靶标疾病网络,从而使用户可以查看和分析药物作用机制。它旨在促进草药的发展,并促进现代医学和传统医学的融合,以促进药物的发现和开发。结论TCMSP的特长在于大量草药的成分,识别药物靶点网络和药物疾病网络的能力,这将有助于揭示中草药的作用机理,揭示中医理论的本质并开发新的草药药物。 TCMSP可从http://sm.nwsuaf.edu.cn/lsp/tcmsp.php网站免费获得。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号